Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amphastar Pharma
(NQ:
AMPH
)
41.00
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
41.00
Bid (Size)
39.01 (1)
Ask (Size)
42.00 (1)
Prev. Close
41.00
Today's Range
41.00 - 41.00
52wk Range
35.62 - 67.66
Shares Outstanding
48,095,862
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies
April 10, 2024
Amphastar Pharmaceuticals discusses the future of Baqsimi at the Needham Healthcare Conference, highlighting its potential amid a growing market for glucagon products. With promising sales projections...
Via
Benzinga
Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 01, 2024
Via
ACCESSWIRE
Performance
YTD
-34.18%
-34.18%
1 Month
-6.03%
-6.03%
3 Month
-25.75%
-25.75%
6 Month
-9.01%
-9.01%
1 Year
+4.38%
+4.38%
More News
Read More
NASDAQ:AMPH, an undervalued stock with good fundamentals.
March 12, 2024
Via
Chartmill
Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference
March 06, 2024
Via
ACCESSWIRE
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023
February 28, 2024
Via
ACCESSWIRE
Delving into NASDAQ:AMPH's Growth Prospects.
February 28, 2024
Via
Chartmill
Earnings Outlook For Amphastar Pharma
February 27, 2024
Via
Benzinga
Is NASDAQ:AMPH a Fit for Growth Investing Strategies?
February 14, 2024
Via
Chartmill
Is NASDAQ:AMPH a Fit for Growth Investing Strategies?
February 07, 2024
Via
Chartmill
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024
February 20, 2024
Via
ACCESSWIRE
CRISPR Therapeutics Stock Shows Rising Relative Strength, Hits 90+
February 13, 2024
Via
Investor's Business Daily
3 Once-in-a-Lifetime Biotech Stocks With Unprecedented Surge Potential
February 05, 2024
Via
InvestorPlace
Axsome Therapeutics Stock Showing Leadership, Earns 91 RS Rating
January 23, 2024
Via
Investor's Business Daily
Despite its impressive fundamentals, NASDAQ:AMPH remains undervalued.
January 23, 2024
Via
Chartmill
Unlocking the Growth Potential of NASDAQ:AMPH.
January 23, 2024
Via
Chartmill
NASDAQ:AMPH is not too expensive for the growth it is showing.
January 17, 2024
Via
Chartmill
Why NASDAQ:AMPH is Poised for High Growth.
January 16, 2024
Via
Chartmill
Why AMPHASTAR PHARMACEUTICALS IN (NASDAQ:AMPH) qualifies as a high growth stock.
January 02, 2024
Via
Chartmill
What Vitamins Did For Healthy Living, Stemtech Corporation (OTCQB: STEK) Says It Is Doing For Anti-Aging With Stem Cell Nutrition
January 19, 2024
Via
Benzinga
Jim Cramer Says Hold Onto This Biotech Stock: 'I Don't Understand Why It's So Inexpensive'
January 17, 2024
Via
Benzinga
Cassava Sciences Stock Continues Showing Rising Relative Strength
January 16, 2024
Via
Investor's Business Daily
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
January 05, 2024
Via
Investor's Business Daily
Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
Via
ACCESSWIRE
Cytokinetics Stock Jumps To Higher RS Level; Shoots Up On Heart Drug Study
December 28, 2023
Via
Investor's Business Daily
Recursion Pharm Showing Market Leadership As Biotech Stocks Shoot Higher
December 26, 2023
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.